Post by BridgeBio

We showed up at the Endocrine Society’s #ENDO2026 with one goal: Move faster for the people living with ADH1. Here's where we made that visible: 🚐 We revealed our genetic testing van, bringing ADH1 and hypoparathyroidism screening directly to the communities who need answers. Because a diagnosis shouldn't depend on your zip code. 🎤 We took the stage. Our researchers presented clinical data on ADH1, adding to the evidence base that shapes how this condition is identified and managed. 📋 We filled the poster hall. Our ADH1-focused work generated real conversation with endocrinologists, geneticists, and rare disease clinicians from around the world. The science is moving. The data are building. And the people living with ADH1 deserve every minute of that momentum.